FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304014748> ?p ?o ?g. }

• W4304014748 endingPage "194" @default.
• W4304014748 startingPage "187" @default.
• W4304014748 abstract "In a recent trial, hydroxychloroquine (HCQ) treatment reduced the expected rate of disability worsening at 18 months in primary progressive multiple sclerosis (PPMS). Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are emerging biomarkers in multiple sclerosis.We measured NfL and GFAP levels in serum samples from 39 patients with inactive PPMS included in a phase II clinical trial of HCQ treatment in PPMS at multiple time points over 18 months, and investigated the association of these biomarkers with clinical disability at screening and during follow-up. Screening and 12-month retinal nerve fiber layer (RNFL) thickness was also recorded and analyzed.NfL and GFAP levels increased over time, but only significantly from screening to month 6. NfL and GFAP levels did not significantly increase from month 6 up to month 18. At screening, NfL and GFAP levels did not correlate with the Expanded Disability Status Scale (EDSS), and GFAP but not NfL modestly correlated with Timed 25-Foot Walk test (T25FW). Screening NfL and GFAP levels did not predict disability worsening (≥20% worsening on the T25FW) at month 18. RNFL thickness decreased significantly from screening to month 12 and independently predicted disability worsening.In this cohort of people with inactive PPMS, HCQ treatment attenuated the increase of NfL and GFAP after 6 months of treatment and up to 18 months of follow-up, suggesting a treatment effect of HCQ over these biomarkers. RNFL thickness, a marker of neuroaxonal atrophy, was associated with disability worsening, and should be explored further as a prognostic marker in this population." @default.
• W4304014748 created "2022-10-10" @default.
• W4304014748 creator A5007367251 @default.
• W4304014748 creator A5010582161 @default.
• W4304014748 creator A5031963674 @default.
• W4304014748 creator A5059402979 @default.
• W4304014748 creator A5087264923 @default.
• W4304014748 date "2022-10-25" @default.
• W4304014748 modified "2023-10-16" @default.
• W4304014748 title "Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis" @default.
• W4304014748 cites W1438178323 @default.
• W4304014748 cites W1965015422 @default.
• W4304014748 cites W1990040006 @default.
• W4304014748 cites W2025916537 @default.
• W4304014748 cites W2087191746 @default.
• W4304014748 cites W2107008240 @default.
• W4304014748 cites W2121568944 @default.
• W4304014748 cites W2296989255 @default.
• W4304014748 cites W2565433170 @default.
• W4304014748 cites W2790816436 @default.
• W4304014748 cites W2906455140 @default.
• W4304014748 cites W2914396477 @default.
• W4304014748 cites W2925266449 @default.
• W4304014748 cites W2964809616 @default.
• W4304014748 cites W3015359871 @default.
• W4304014748 cites W3025963287 @default.
• W4304014748 cites W3026936125 @default.
• W4304014748 cites W3039131552 @default.
• W4304014748 cites W3042931334 @default.
• W4304014748 cites W3096539291 @default.
• W4304014748 cites W3120882765 @default.
• W4304014748 cites W3132472946 @default.
• W4304014748 cites W3133805595 @default.
• W4304014748 cites W3175893435 @default.
• W4304014748 cites W3191558984 @default.
• W4304014748 cites W3201687379 @default.
• W4304014748 cites W3208672684 @default.
• W4304014748 cites W4210864910 @default.
• W4304014748 cites W4213333572 @default.
• W4304014748 cites W4220885711 @default.
• W4304014748 cites W4226153130 @default.
• W4304014748 doi "https://doi.org/10.1111/ene.15588" @default.
• W4304014748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36214614" @default.
• W4304014748 hasPublicationYear "2022" @default.
• W4304014748 type Work @default.
• W4304014748 citedByCount "1" @default.
• W4304014748 crossrefType "journal-article" @default.
• W4304014748 hasAuthorship W4304014748A5007367251 @default.
• W4304014748 hasAuthorship W4304014748A5010582161 @default.
• W4304014748 hasAuthorship W4304014748A5031963674 @default.
• W4304014748 hasAuthorship W4304014748A5059402979 @default.
• W4304014748 hasAuthorship W4304014748A5087264923 @default.
• W4304014748 hasConcept C118487528 @default.
• W4304014748 hasConcept C126322002 @default.
• W4304014748 hasConcept C142724271 @default.
• W4304014748 hasConcept C203014093 @default.
• W4304014748 hasConcept C204232928 @default.
• W4304014748 hasConcept C2779123688 @default.
• W4304014748 hasConcept C2779134260 @default.
• W4304014748 hasConcept C2780495277 @default.
• W4304014748 hasConcept C2780592520 @default.
• W4304014748 hasConcept C2780640218 @default.
• W4304014748 hasConcept C2780827179 @default.
• W4304014748 hasConcept C2780892749 @default.
• W4304014748 hasConcept C2781137167 @default.
• W4304014748 hasConcept C2781197716 @default.
• W4304014748 hasConcept C3008058167 @default.
• W4304014748 hasConcept C524204448 @default.
• W4304014748 hasConcept C55493867 @default.
• W4304014748 hasConcept C71924100 @default.
• W4304014748 hasConcept C86803240 @default.
• W4304014748 hasConcept C90924648 @default.
• W4304014748 hasConceptScore W4304014748C118487528 @default.
• W4304014748 hasConceptScore W4304014748C126322002 @default.
• W4304014748 hasConceptScore W4304014748C142724271 @default.
• W4304014748 hasConceptScore W4304014748C203014093 @default.
• W4304014748 hasConceptScore W4304014748C204232928 @default.
• W4304014748 hasConceptScore W4304014748C2779123688 @default.
• W4304014748 hasConceptScore W4304014748C2779134260 @default.
• W4304014748 hasConceptScore W4304014748C2780495277 @default.
• W4304014748 hasConceptScore W4304014748C2780592520 @default.
• W4304014748 hasConceptScore W4304014748C2780640218 @default.
• W4304014748 hasConceptScore W4304014748C2780827179 @default.
• W4304014748 hasConceptScore W4304014748C2780892749 @default.
• W4304014748 hasConceptScore W4304014748C2781137167 @default.
• W4304014748 hasConceptScore W4304014748C2781197716 @default.
• W4304014748 hasConceptScore W4304014748C3008058167 @default.
• W4304014748 hasConceptScore W4304014748C524204448 @default.
• W4304014748 hasConceptScore W4304014748C55493867 @default.
• W4304014748 hasConceptScore W4304014748C71924100 @default.
• W4304014748 hasConceptScore W4304014748C86803240 @default.
• W4304014748 hasConceptScore W4304014748C90924648 @default.
• W4304014748 hasFunder F4320314105 @default.
• W4304014748 hasIssue "1" @default.
• W4304014748 hasLocation W43040147481 @default.
• W4304014748 hasLocation W43040147482 @default.
• W4304014748 hasOpenAccess W4304014748 @default.
• W4304014748 hasPrimaryLocation W43040147481 @default.

• next